JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) FCF Yield % : -53.02 (As of May. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, JW (Cayman) Therapeutics Co's Trailing 12-Month Free Cash Flow is $-68.36 Mil, and Market Cap is $125.66 Mil. Therefore, JW (Cayman) Therapeutics Co's FCF Yield % for today is -53.02%.

The historical rank and industry rank for JW (Cayman) Therapeutics Co's FCF Yield % or its related term are showing as below:

JWCTF' s FCF Yield % Range Over the Past 10 Years
Min: -92.31 Med: -50.39 Max: -15.96
Current: -53.02

During the past 6 years, the highest FCF Yield % of JW (Cayman) Therapeutics Co was -15.96%. The lowest was -92.31%. And the median was -50.39%.

JWCTF's FCF Yield % is ranked worse than
75.55% of 1554 companies
in the Biotechnology industry
Industry Median: -14.38 vs JWCTF: -53.02

JW (Cayman) Therapeutics Co's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

JW (Cayman) Therapeutics Co FCF Yield % Historical Data

The historical data trend for JW (Cayman) Therapeutics Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW (Cayman) Therapeutics Co FCF Yield % Chart

JW (Cayman) Therapeutics Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-13.52

-44.14

-52.49

JW (Cayman) Therapeutics Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial						-12.59	-29.04	-32.99	-43.96	-

Competitive Comparison of JW (Cayman) Therapeutics Co's FCF Yield %

For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW (Cayman) Therapeutics Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where JW (Cayman) Therapeutics Co's FCF Yield % falls into.

JW (Cayman) Therapeutics Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

JW (Cayman) Therapeutics Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-57.841	/	110.1922112
	=	-52.49%

JW (Cayman) Therapeutics Co's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	2	/	110.1922112
	=	0.00%

JW (Cayman) Therapeutics Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

JW (Cayman) Therapeutics Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

02126:Hong Kong

Address

No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN

Website

https://www.jwtherapeutics.com

JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Headlines

No Headlines